breast cancer Archives | Be Korea-savvy

Home / Posts tagged breast cancer

Wistar Researchers Discover Possible New Treatment for Triple-Negative Breast Cancer

PHILADELPHIA, PA, Sept. 19 (Korea Bizwire) – Zachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogenesis Program of the Ellen and Ronald Caplan Cancer Center at The Wistar Institute, has published a new paper in the journal Nature Cancer. Schug’s paper — titled, “Acetate acts as a metabolic immunomodulator by bolstering T-cell effector function and potentiating antitumor immunity in breast cancer” — [...]

Mediterranean Diet Helps Prevent Breast Cancer by Suppressing Obesity: Study

SEOUL, Aug. 24 (Korea Bizwire) — Mediterranean food, with abundant fiber and unsaturated fat, can lower the risk of breast cancer by suppressing obesity, a study indicated Tuesday. A joint research team from Severance Hospital and Chaum Life Center offered a Mediterranean diet to 35 patients with stage 1 to 3 breast cancer for eight [...]

First CE-IVD Marked AI Solution for Prognostic Risk Stratification of Breast Cancer Patients

Stockholm, Sweden, June 1 (Korea Bizwire) — Stratipath, a global leader in AI-based precision diagnostic solutions, today announced that its AI software for prognostic risk stratification of breast cancers, Stratipath Breast, is now CE-IVD marked. This paves the way for clinical implementation in the European Union. Based on the analysis of digital histopathology whole slide images, stained with haematoxylin and eosin (H&E) the software provides novel decision support to [...]

S. Korean Institute Develops AR Technology for Breast Cancer Surgery

GWANGJU, May 31 (Korea Bizwire) — The Korea Photonics Technology Institute said Monday it has developed a free-space augmented reality (AR) system that allows examination of the exact location and shape of breast cancer tissue through the naked eye, without using separate AR glasses or other supplementary devices. The technology, developed jointly by the institute, [...]

Philips PACS Interoperability Helps Scotland’s National Health Service Deliver Leading Breast Cancer Screening

Amsterdam, the Netherlands and Orlando, Florida, USA, March 16 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and NHS National Services Scotland, a non-departmental public body that provides advice and services to National Health Service (NHS) Scotland, today revealed the impact of the COVID-19 pandemic on the Scottish Breast Screening [...]

TRIO Enrols First Patient in Global Phase 3 Giredestrant Early Breast Cancer Trial

EDMONTON, Alberta, Aug. 31 (Korea Bizwire) — Translational Research in Oncology (TRIO), a global academic clinical research organization, announced today enrolment of first patient in the LidERA Breast Cancer (TRIO045) trial, a Phase 3 randomized, multi-center, open-label global clinical trial of adjuvant endocrine therapy, giredestrant (GDC-9545) sponsored by F. Hoffmann-LaRoche. Giredestrant is an oral selective [...]

TRIO Completes Enrolment for Phase 2 Giredestrant Early Breast Cancer Trial Ahead of Schedule

EDMONTON, Alberta, July 6 (Korea Bizwire) — Translational Research in Oncology (TRIO), a global academic clinical research organization, announced today enrolment completion in coopERA Breast Cancer (WO42133/TRIO038), a Phase 2 randomized, multi-center, open-label clinical trial of giredestrant (GDC-9545) sponsored by F. Hoffmann-La Roche. This comes shortly after completion of the planned study interim analysis provided [...]

AI Offers Accurate Prediction of Chemotherapy Effectiveness Prior to Breast Cancer Surgery

SEOUL, Dec. 7 (Korea Bizwire) — South Korean researchers have developed new technology that uses artificial intelligence (AI) to anticipate the effects of chemotherapy for breast cancer patients. The Korea Institute of Radiological Medical Sciences announced recently that an AI deep learning mechanism can be used to anticipate the effects of chemotherapy for breast cancer [...]

Areolar Incision Technique Brings New Hope to Breast Cancer Patients

SEOUL, Dec. 2 (Korea Bizwire) — The scars left after breast cancer surgery are among the factors that greatly worsen quality of life for patients. Fortunately, however, the areolar incision technique is emerging as an alternative that leaves almost no scars. A recent study showed that the areolar incision technique has no significant differences in [...]

Samsung Bioepis’ Breast Cancer Biosimilar Hits U.S.

SEOUL, April 16 (Korea Bizwire) — South Korean biopharmaceutical firm Samsung Bioepis Co. said Thursday its breast cancer biosimilar Ontruzant is now available in the United States. Global health care company MSD has begun distributing the biosimilar that references Switzerland-based Roche Holding’s Herceptin, also known as Trastuzumab, in the world’s largest pharmaceutical market, Samsung Bioepis [...]